3 AI Spend Metrics That Keep Me Buying Meta Leading Up to July 29 Earnings Report

Photo of Alex Sirois
By Alex Sirois Published

Quick Read

  • Meta's AI-powered ad tools drove Q1 revenue up 33% to $56.31B while holding a 41% operating margin at a forward P/E of 21.

  • Meta's value optimization suite now runs at a $20B annual revenue run rate, doubling year over year, with 8 million advertisers using GenAI creative tools.

  • Full-year 2026 capex was raised to a range of $125B to $145B, yet a 91% Polymarket probability of a July 29 beat keeps the bull thesis intact.

  • Act now: the analyst who called NVIDIA in 2010 just named his top 10 AI stocks — and Meta didn't make the cut. Grab the names FREE today.

3 AI Spend Metrics That Keep Me Buying Meta Leading Up to July 29 Earnings Report

© Fritz Jorgensen / iStock Editorial via Getty Images

I keep hitting the buy button on Meta Platforms (NASDAQ:META | META Price Prediction) because I have finally seen a hyperscaler turn a compute bill into a receipt in the same quarter it wrote the check. That is the whole confession. Three AI spend metrics keep me coming back, and July 29 is not going to change what has already been proved on the income statement.

The Ad Auction Yield Loop

The first metric is the one nobody can argue with. In Q1 2026, ad impressions across the Family of Apps grew 19% year over year while average price per ad climbed 12%. That is a Lattice and adaptive ranking story, and Susan Li spelled it out on the call: enhancements to Lattice modeling drove a “more than 6% increase in conversion rate for landing page view ads,” and the adaptive ranking model added another 1.6% conversion lift on major Facebook and Instagram surfaces. GPU clusters are being converted into higher ARPP in the same quarter they are installed. Total revenue rose 33.08% to $56.31 billion. That is my ad auction yield loop.

New Commercial Revenue Streams

The second metric is the one the bears are ignoring. Meta Superintelligence Labs shipped Muse Spark, and Li disclosed that the value optimization suite is now running at an annual revenue run rate of over $20 billion, more than doubling year over year. Business AI conversations went from 1 million to more than 10 million per week inside a single year. More than 8 million advertisers are using GenAI ad creative tools. Zuckerberg said Meta is “on track to deliver personal superintelligence to billions of people.” That is a monetization surface that did not exist two years ago.

Operating Margin Defense

The third metric is the one that lets me sleep. Full-year 2026 capex was raised to $125 to $145 billion, and Q1 capex alone was $18.997 billion, up 46.8% year over year. Yet full-year expense guidance stayed pinned at $162 to $169 billion, unchanged. Q1 operating margin held at 41%. Operating cash flow of $32.23 billion, up 34.13%, is funding the buildout. Debt/equity sits at 0.386 with interest coverage of 71.48x. ROE is 30.24%, ROIC 20.69%. That is discipline, not sprawl.

Why Meta, Not Alphabet

Alphabet was the obvious alternative for the ad-plus-AI trade. I passed. Meta grew top-line 33.08% in Q1 while running a 41% operating margin and a forward P/E of 21. That combination of growth rate, margin, and multiple is what pulled my money here. This is a purer ad-auction compounder without a cloud segment diluting the AI attribution story.

The Real Risk

The risk that could actually hurt me is capex ROI. Reality Labs lost $4.03 billion in Q1, total expenses grew 35% year over year, and Li admitted Meta has “continued to underestimate our compute needs.” If the auction yield loop stalls, the depreciation wave will hit hard. I am watching it. What keeps the thesis intact: five consecutive EPS beats, Q1 EPS of $10.44 against a $6.6587 estimate, and a Polymarket crowd pricing a 91% probability of another beat on July 29.

At $664.54, with 3.56 billion daily active people being monetized more efficiently every quarter, the buy button stays active because the receipts do.

Contact [email protected] for any questions or corrections.

Photo of Alex Sirois
About the Author Alex Sirois →

Alex Sirois is a financial writer with experience spanning both retail and institutional investing. He has written for InvestorPlace and held roles at BNY Mellon and Bernstein, giving him a perspective that bridges Main Street portfolios and Wall Street analysis.

Alex holds an MBA from George Washington University and has built his career across multiple industries, including e-commerce, education, and translation — a breadth of experience that informs how he breaks down complex financial topics for everyday investors. His writing is conversational, actionable, and grounded in long-term, buy-and-hold investing principles.

At 247 Wall St., Alex focuses on delivering analysis that is both accessible and useful, with a clear emphasis on helping readers make more informed decisions with their money.

Continue Reading

Top Gaining Stocks

TRV Vol: 2,790,935
STX Vol: 5,056,945
HP
HPQ Vol: 9,710,693
WDC Vol: 8,800,429
HUM Vol: 705,661

Top Losing Stocks

ISRG Vol: 7,833,479
CDNS Vol: 3,450,925
SNPS Vol: 3,219,619
CTRA Vol: 73,319,495
NFLX Vol: 100,128,504